ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,745.37
      0.40%
      US Tech 100
      19,580.43
      0.76%
      Dow Jones
      42,175.11
      0.62%
      Brent Oil
      70.955
      -3.05%
      Bitcoin
      64,801.06
      2.64%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cingulate Inc (CING)

      7. Cingulate Inc (CING) News

      CING

      Cingulate (CING)

      Cingulate Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CING
      DateTimeSourceHeadlineSymbolCompany
      09/12/20248:30AMGlobeNewswire Inc.Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301NASDAQ:CINGCingulate Inc
      09/03/20249:15AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CINGCingulate Inc
      09/03/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      08/30/20246:00PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CINGCingulate Inc
      08/29/20246:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      08/28/202412:54PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      08/28/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CINGCingulate Inc
      08/27/20244:42PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CINGCingulate Inc
      08/27/20244:30PMGlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access EventNASDAQ:CINGCingulate Inc
      08/23/20244:55PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CINGCingulate Inc
      08/23/20244:45PMGlobeNewswire Inc.Cingulate Announces Adjournment of Special MeetingNASDAQ:CINGCingulate Inc
      08/20/20247:00PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CINGCingulate Inc
      08/19/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
      08/19/20246:39AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CINGCingulate Inc
      08/19/20246:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      08/19/20246:03AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CINGCingulate Inc
      08/15/20247:45AMGlobeNewswire Inc.Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHDNASDAQ:CINGCingulate Inc
      08/13/20248:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CINGCingulate Inc
      08/13/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      08/13/20247:45AMGlobeNewswire Inc.Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones AchievedNASDAQ:CINGCingulate Inc
      08/07/20249:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      07/30/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
      07/25/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CINGCingulate Inc
      07/24/20245:11PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CINGCingulate Inc
      07/22/20245:04PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CINGCingulate Inc
      07/16/20247:14PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CINGCingulate Inc
      07/15/20245:06PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CINGCingulate Inc
      07/15/20245:01PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CINGCingulate Inc
      07/12/20245:11PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CINGCingulate Inc
      07/12/20244:30PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CINGCingulate Inc
       Showing the most relevant articles for your search:NASDAQ:CING